Home LiteratureArticle Details
PMID: 8793400 Published · ppublish English Clinical Trial Journal Article

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.

Denton M, Todd NJ, Littlewood JM

Abstract

A retrospective case-control study of 12 patients positive for Stenotrophomonas maltophilia and 24 age-sex-matched controls revealed that in the year prior to initial isolation, colonised patients spent more days in hospital and received more days of oral ciprofloxacin, intravenous anti-pseudomonal antibiotics, and nebulised aminoglycosides. They were also more likely to have grown Pseudomonas aeruginosa at some time in the past, despite there being no difference in current chronic infection with this organism. The role of anti-pseudomonal antibiotics in promoting Stenotrophomonas maltophilia colonisation in cystic fibrosis is discussed.

MeSH Terms
Adolescent Aminoglycosides Anti-Bacterial Agents/pharmacology,therapeutic use Case-Control Studies Child Child, Preschool Chronic Disease Cystic Fibrosis/complications Female Humans Male Microbial Sensitivity Tests Pseudomonas Infections/complications,drug therapy Pseudomonas aeruginosa/drug effects,isolation & purification Retrospective Studies Treatment Outcome
Chemicals
Aminoglycosides Anti-Bacterial Agents
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Denton M
Department of Microbiology, St. James's University Hospital, Leeds, UK.
Todd N J
Littlewood J M
References (11)
11 references, click to expand
  1. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.
    Rev Infect Dis. 1990 Nov-Dec;12(6):997-1003 PMID: 2267495
  2. Stenotrophomonas maltophilia in cystic fibrosis patients.
    Eur J Clin Microbiol Infect Dis. 1995 Aug;14(8):728-9 PMID: 8565998
  3. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
    J Hosp Infect. 1995 Jun;30 Suppl:453-64 PMID: 7560984
  4. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.
    Arch Dis Child. 1992 Feb;67(2):192-5 PMID: 1371914
  5. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR.
    J Clin Microbiol. 1995 Apr;33(4):912-4 PMID: 7790459
  6. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.
    Lancet. 1985 Apr 13;1(8433):865 PMID: 2858720
  7. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
    Antimicrob Agents Chemother. 1992 Mar;36(3):669-71 PMID: 1622183
  8. Use of antibiotics in cystic fibrosis. The Danish approach.
    Antibiot Chemother (1971). 1989;42:237-46 PMID: 2688545
  9. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
    J Clin Microbiol. 1996 Mar;34(3):584-7 PMID: 8904419
  10. Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
    Acta Paediatr. 1993 Mar;82(3):308-9 PMID: 8495091
  11. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Lancet. 1991 Sep 21;338(8769):725-6 PMID: 1679870
Article Info
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Abbr.
Eur J Clin Microbiol Infect Dis
ISSN
0934-9723
Published
1996-05-00
Pages
402-5
Language
English
Region
Germany
NLM ID
8804297
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]